公司简介

Actavis is a leading pharmaceutical group ranked first 50 in worldwide pharmaceutical industry, and 3rd in global generic field with the headquarter located in Jersey, USA. Actavis develops its business in over 60 countries or regions, selling more than 1000 kinds of products. Actavis also has over 600 kinds of products being developed or registered at present. All the products cover in central nervous system, alimentary tract, cardiovascular system, metabolism, anti-infectives, respiratory system, etc.

公司发展

Actavis (Foshan) is the production, sales & marketing and R&D base in China for Actavis Group. The earliest predecessor of Actavis (Foshan) is the Foshan pharmaceutical plant, which was founded in 1958, and acquired by FH Faulding from Australia in 1994, then by Alpharma from USA in 2001. Actavis (Foshan) became part of Actavis group in late 2005 with the formal name of Actavis (Foshan) Pharmaceutical Co., Ltd.

阿特维斯集团是一间总部位于美国新泽西州的制药公司，位居全球医药企业50强，全球通用名药企业第3强，其业务遍及全球60多个国家或地区。目前在产和销售的产品1000多种，研发中和注册中的产品600多种，涉及中枢神经、消化、心血管、代谢、抗感染、呼吸等多个领域。

阿特维斯（佛山）制药有限公司是阿特维斯集团在中国的研发、生产和销售基地，其前身是成立于1960年的佛山制药厂，后来历经澳洲康宝顺（佛山）制药有限公司、美国雅来（佛山）制药有限公司，在2005年底发展成为现在的阿特维斯（佛山）制药有限公司。

阿特维斯坚持在研发，生产与服务都执行最高标准。我们欢迎与全国经销商一起为顾客提供“欧盟品质、中国价格”的好药。中国大陆区业务作为阿特维斯全集团发展战略重要的一环，其光明的前景势必为全集团成为更优秀的通用名药企业做出巨大贡献。